Ozics AG
Bone reinforcement composite for hip fractures
This article was originally published in Start Up
Executive Summary
Although standard bone cements are commonly used to treat vertebral compression fractures, these cements are not durable enough to remedy fractured hips. But a new class of biomaterials could dramatically change the landscape. Switzerland’s Ozics AG says its injectable and load-bearing implant provides an optimal level of biomechanical performance through a minimally invasive procedure.
You may also be interested in...
FDA Officials Cite Reasons For Denying Application Reviews Over Data Integrity Breaches
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
Vaccinex Sees Mixed Signals In Huntington’s Study
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
Approval Of BMS/Bluebird’s Ide-Cel May Come Just In Time
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.
Need a specific report? 1000+ reports available Buy Reports
Register for our free email digests: